Human Trial Shows Engineered Immune Cells Could Help Fight Leukemia | IFLScience

A treatment that was awarded Breakthrough Therapy designation by the FDA last year is once again raising hopes for those with B cell cancers. In a recently completed trial, eight out of 14 leukemia patients responded to the novel treatment, a type of personalized cell therapy. Encouragingly, some also went into remission and have remained cancer-free for more than four and a half years.

Source: Human Trial Shows Engineered Immune Cells Could Help Fight Leukemia | IFLScience

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s